Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohammed Saied Bakeer, Mohamed Ibrahim Youssef, Helmy M Elshazly, Mohamed Abdel-Samiee, Abdelaleem A El-Gendy, M Abouzed, Warda Othman, Mervat Abdelkareem, Mai Abozeid, Samah Mohammed Awad, Fatma O Khalil, Hanan M Bedair, Karema A Diab, A S Seif, Marwa F Youssef, Ayman Ahmed Sakr & Eman Abdelsameea. (2019) On-treatment improvement of an emerging psychosomatic depressive disorder among salmonella carriers: a multicenter experience from Egypt. Infection and Drug Resistance 12, pages 2573-2582.
Read now
Read now
Donald P Rogers & Carroll-Ann W Goldsmith. (2009) Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis. Expert Review of Neurotherapeutics 9:1, pages 47-54.
Read now
Read now
Articles from other publishers (87)
Stephanie Fryar-Williams, Jörg Strobel & Peter Clements. (2023) Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis. International Journal of Molecular Sciences 24:20, pages 15296.
Crossref
Crossref
Mark Weiser, Linda Levi, Jinyoung Park, Igor Nastas, Valentin Matei, Michael Davidson, Ido Arad, Israel Dudkiewicz & John M. Davis. (2023) A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder. European Neuropsychopharmacology 73, pages 65-74.
Crossref
Crossref
Atike Gül Çakıl, Hasan Kaya, Arzu Sakallı Nural, Işık Batuhan Çakmak, İhsan Tuncer Okay & Erol Göka. (2023) Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α (TNF-α) levels in patients with schizophrenia. Psychopharmacology 240:5, pages 1091-1101.
Crossref
Crossref
Aya-Ebi Okubo Eneni, Benneth Ben-Azu, Abayomi Mayowa Ajayi & Adegbuyi Oladele Aderibibge. (2023) Lipopolysaccharide Exacerbates Ketamine-Induced Psychotic-Like Behavior, Oxidative Stress, and Neuroinflammation in Mice: Ameliorative Effect of Diosmin. Journal of Molecular Neuroscience 73:2-3, pages 129-142.
Crossref
Crossref
Sarah K. Royse, Brian J. Lopresti, Chester A. Mathis, Savannah Tollefson & Rajesh Narendran. (2022) Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders. Journal of Neurochemistry 164:3, pages 401-443.
Crossref
Crossref
William W. Eaton, Katrina M. Rodriguez, Mekha A. Thomas, Jeanette Johnson, Monica V. Talor, Curtis Dohan, Clifton O. BinghamIIIIII, Rashelle Musci, Kimberly Roth, Deanna L. Kelly, Daniela Cihakova & Erika Darrah. (2022) Immunologic profiling in schizophrenia and rheumatoid arthritis. Psychiatry Research 317, pages 114812.
Crossref
Crossref
Mahsa Motamed, Hanieh Karimi, Hossein Sanjari Moghaddam, Sina Taherzadeh Boroujeni, Zahra Sanatian, Alireza Hasanzadeh, Mohammad-Reza Khodaei Ardakani & Shahin Akhondzadeh. (2022) Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial. International Clinical Psychopharmacology 37:3, pages 92-101.
Crossref
Crossref
Dawit T Zemedikun, Joht Singh Chandan, Devan Raindi, Amarkumar Dhirajlal Rajgor, Krishna Margadhmane Gokhale, Tom Thomas, Marie Falahee, Paola De Pablo, Janet M Lord, Karim Raza & Krishnarajah Nirantharakumar. (2021) Burden of chronic diseases associated with periodontal diseases: a retrospective cohort study using UK primary care data. BMJ Open 11:12, pages e048296.
Crossref
Crossref
Yan Zhang, Han Shi, Ge Yang, Yongfeng Yang, Wenqiang Li, Meng Song, Minglong Shao, Xi Su & Luxian Lv. (2021) Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia. Translational Psychiatry 11:1.
Crossref
Crossref
Mark Weiser, Daisy Zamora, Linda Levi, Igor Nastas, Ilan Gonen, Paull Radu, Valentin Matei, Anatol Nacu, Larisa Boronin, Michael Davidson & John M Davis. (2021) Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials. Schizophrenia Bulletin 47:4, pages 1077-1087.
Crossref
Crossref
Putra M. Mahmuddin, Elmeida Efffendy & Mustafa M. Amin. (2021) Correlation between C-reactive Protein Levels with Cognitive Function and Body Mass Index in Schizophrenia. Open Access Macedonian Journal of Medical Sciences 9:T3, pages 228-231.
Crossref
Crossref
Mustafa Mahmud Amin & Elmeida Effendy. (2021) Cytokine Level and Symptoms of Schizophrenia. Open Access Macedonian Journal of Medical Sciences 9:T3, pages 87-91.
Crossref
Crossref
Marcella Reale, Erica Costantini & Nigel H. Greig. (2021) Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment. Frontiers in Psychiatry 12.
Crossref
Crossref
Eleonora Gatta, Vikram Saudagar, Jenny Drnevich, Marc P Forrest, James Auta, Lindsay V Clark, Henry Sershen, Robert C Smith, Dennis R Grayson, John M Davis & Alessandro Guidotti. (2021) Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia. Schizophrenia Bulletin Open 2:1.
Crossref
Crossref
V. E. Pashkovskiy. (2020) Late schizophrenia. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY:4, pages 3-11.
Crossref
Crossref
Robert W. Buchanan, Elaine Weiner, Deanna L. Kelly, James M. Gold, Shuo Chen, Jennifer Zaranski, Frank Blatt, Heidi Wehring & William T. Carpenter. (2020) Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology 40:5, pages 444-450.
Crossref
Crossref
Scott Teasdale, Sabrina Mörkl & Annabel Sandra Müller-Stierlin. (2020) Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges. Brain, Behavior, & Immunity - Health 5, pages 100070.
Crossref
Crossref
Nicolas Vignal, Anne-Cécile Boulay, Carine San, Martine Cohen-Salmon, Nathalie Rizzo-Padoin, Laure Sarda-Mantel, Xavier Declèves, Salvatore Cisternino & Benoît Hosten. (2020) Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F]FEPPA. Cells 9:2, pages 389.
Crossref
Crossref
Karina S. MacDowell, Marina Díaz Marsá, Eva Buenache, Jose M López Villatoro, Beatriz Moreno, Juan C Leza & José L Carrasco. (2020) Inflammatory and antioxidant pathway dysfunction in borderline personality disorder. Psychiatry Research 284, pages 112782.
Crossref
Crossref
Sri Mahavir Agarwal, Fernando Caravaggio, Kenya A. Costa-Dookhan, Laura Castellani, Chantel Kowalchuk, Roshanak Asgariroozbehani, Ariel Graff-Guerrero & Margaret Hahn. (2020) Brain insulin action in schizophrenia: Something borrowed and something new. Neuropharmacology 163, pages 107633.
Crossref
Crossref
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, George Anderson, Marta Kubera, Andre F. Carvalho & Michael Maes. (2019) The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia. Molecular Neurobiology 57:2, pages 778-797.
Crossref
Crossref
Rabia Nazik Yüksel, Ayşe Pınar Titiz, Elif Tatlıdil Yaylacı, Kübranur Ünal, Turan Turhan, Gamze Erzin, Cevdet Züngün, Makbule Çiğdem Aydemir & Erol Göka. (2019) Serum PGE2, 15d-PGJ, PPARγ and CRP levels in patients with schizophrenia. Asian Journal of Psychiatry 46, pages 24-28.
Crossref
Crossref
Magnus Sjögren, Stein Frostad & Kenneth Klingenberg Barfod. 2019. Anorexia and Bulimia Nervosa. Anorexia and Bulimia Nervosa.
Lulu Zhang, Hongbo Zheng, Rengrong Wu, Thomas R. Kosten, Xiang-Yang Zhang & Jingping Zhao. (2019) The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia. Schizophrenia Research 212, pages 92-98.
Crossref
Crossref
Rickinder Sethi, Nieves Gómez-Coronado, Adam J. Walker, Oliver D’Arcy Robertson, Bruno Agustini, Michael Berk & Seetal Dodd. (2019) Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. Frontiers in Psychiatry 10.
Crossref
Crossref
Gregory N. BratmanChristopher B. Anderson, Marc G. Berman, Bobby Cochran, Sjerp de Vries, Jon Flanders, Carl Folke, Howard Frumkin, James J. GrossTerry Hartig, Peter H. KahnJr.Jr., Ming Kuo, Joshua J. Lawler, Phillip S. Levin, Therese LindahlAndreas Meyer-Lindenberg, Richard Mitchell, Zhiyun Ouyang, Jenny RoeLynn ScarlettJeffrey R. Smith, Matilda van den BoschBenedict W. Wheeler, Mathew P. White, Hua Zheng & Gretchen C. Daily. (2019) Nature and mental health: An ecosystem service perspective. Science Advances 5:7.
Crossref
Crossref
Afsane Bahrami, Hamidreza Bahrami-Taghanaki, Zahra Khorasanchi, Maryam Tayefi, Gordon A. Ferns, Hamid Reza Sadeghnia & Majid Ghayour-Mobarhan. (2019) The Association Between Neuropsychological Function with Serum Vitamins A, D, and E and hs-CRP Concentrations. Journal of Molecular Neuroscience 68:2, pages 243-250.
Crossref
Crossref
Jingbo Gong, Ya Wang, Jianbo Liu, Xiaogao Fu, Eric F.C. Cheung & Raymond. C.K. Chan. (2019) The interaction between positive schizotypy and high sensitivity C-reactive protein on response inhibition in female individuals. Psychiatry Research 274, pages 365-371.
Crossref
Crossref
Hovsep Ghazaryan, Roksana Zakharyan, Martin Petrek, Zdenka Navratilova, Andranik Chavushyan, Eva Novosadova & Arsen Arakelyan. (2019) Expression of micro-RNAs miR-31, miR-146a, miR-181c and miR-155 and their target gene IL-2 are altered in schizophrenia: a case-control study. F1000Research 8, pages 2077.
Crossref
Crossref
Xiuling Wang, Jin Huang & Fan Zhu. (2018) Human Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases. Frontiers in Psychiatry 9.
Crossref
Crossref
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, Carlos Spuch, Hector J. Caruncho, África González-Fernandez, Jose M. Olivares & Roberto C. Agís-Balboa. (2018) Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophrenia Research 197, pages 19-33.
Crossref
Crossref
Furong Zhu, Lulu Zhang, Fang Liu, Renrong Wu, Wenbin Guo, Jianjun Ou, Xiangyang Zhang & Jingping Zhao. (2018) Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia. Frontiers in Neuroscience 12.
Crossref
Crossref
Jana Caylor Bowcut & Mark Weiser. (2018) Inflammation and Schizophrenia. Psychiatric Annals 48:5, pages 237-243.
Crossref
Crossref
Davide Pozzi, Elisabetta Menna, Alice Canzi, Genni Desiato, Cristina Mantovani & Michela Matteoli. (2018) The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Fang Liu, Liqin Xie, Bingkui Zhang, Ye Ruan, Yong Zeng, XiuFeng Xu, Jingping Zhao & Xiaoduo Fan. (2018) No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia. Journal of Clinical Psychopharmacology 38:2, pages 125-128.
Crossref
Crossref
Yanli Luo, Fang Liu, Radhika Natarajan, Nawras Shukair, Paul Copeland & Xiaoduo Fan. (2018) Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia. International Clinical Psychopharmacology 33:2, pages 88-91.
Crossref
Crossref
E Effendy. (2018) Exploring the link between inflammation and mental disorders. IOP Conference Series: Earth and Environmental Science 125, pages 012187.
Crossref
Crossref
Sumedha Mitra, Radhika Natarajan, Douglas Ziedonis & Xiaoduo Fan. (2017) Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, pages 1-11.
Crossref
Crossref
Silke Braun, René Bridler, Norbert Müller, Markus J. Schwarz, Erich Seifritz, Matthias Weisbrod, Alexandra Zgraggen & Hans H. Stassen. (2017) Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders. European Archives of Psychiatry and Clinical Neuroscience 267:5, pages 377-389.
Crossref
Crossref
Qinting Zhang, Wu Hong, Haozhe Li, Fanglan Peng, Fan Wang, Ningning Li, Hui Xiang, Zongfeng Zhang, Yousong Su, Yueqi Huang, Shengyu Zhang, Guoqin Zhao, Rubai Zhou, Ling Mao, Zhiguang Lin, Weixiong Cai, Yiru Fang, Bin Xie & Min Zhao. (2017) Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression. International Journal of Psychophysiology 114, pages 9-15.
Crossref
Crossref
Jamie Joseph, Colin Depp, Pei-an B. Shih, Kristen S. Cadenhead & Geert Schmid-Schönbein. (2017) Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?. Frontiers in Neuroscience 11.
Crossref
Crossref
Yin Yang Fu, Tong Zhang, Mei Hong Xiu, Wei Tang, Mei Han, Long Tan Yun, Da Chun Chen, Song Chen, Shu Ping Tan, Jair C. Soares, Wen Jie Tang & Xiang Yang Zhang. (2016) Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. Schizophrenia Research 176:2-3, pages 196-200.
Crossref
Crossref
Bram. P. Prins, Ali Abbasi, Anson Wong, Ahmad Vaez, Ilja Nolte, Nora Franceschini, Philip E. Stuart, Javier Guterriez Achury, Vanisha Mistry, Jonathan P. Bradfield, Ana M. Valdes, Jose Bras, Aleksey Shatunov, Chen Lu, Buhm Han, Soumya Raychaudhuri, Steve Bevan, Maureen D. Mayes, Lam C. Tsoi, Evangelos Evangelou, Rajan P. Nair, Struan F. A. Grant, Constantin Polychronakos, Timothy R. D. Radstake, David A. van Heel, Melanie L. Dunstan, Nicholas W. Wood, Ammar Al-Chalabi, Abbas Dehghan, Hakon Hakonarson, Hugh S. Markus, James T. Elder, Jo Knight, Dan E. Arking, Timothy D. Spector, Bobby P. C. Koeleman, Cornelia M. van Duijn, Javier Martin, Andrew P. Morris, Rinse K. Weersma, Cisca Wijmenga, Patricia B. Munroe, John R. B. Perry, Jennie G. Pouget, Yalda Jamshidi, Harold Snieder & Behrooz Z. Alizadeh. (2016) Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. PLOS Medicine 13:6, pages e1001976.
Crossref
Crossref
G B Rogers, D J Keating, R L Young, M-L Wong, J Licinio & S Wesselingh. (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular Psychiatry 21:6, pages 738-748.
Crossref
Crossref
Nora Bedrossian, Mariam Haidar, Jawad Fares, Firas H. Kobeissy & Youssef Fares. (2016) Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia. Frontiers in Molecular Neuroscience 9.
Crossref
Crossref
Eric Plitman, Camilo de la Fuente-Sandoval, Francisco Reyes-Madrigal, Sofia Chavez, Gladys Gómez-Cruz, Pablo León-Ortiz & Ariel Graff-Guerrero. (2016) Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction. Schizophrenia Bulletin 42:2, pages 415-424.
Crossref
Crossref
Stefano Marini, Domenico De Berardis, Federica Vellante, Rita Santacroce, Laura Orsolini, Alessandro Valchera, Gabriella Girinelli, Alessandro Carano, Michele Fornaro, Francesco Gambi, Giovanni Martinotti & Massimo Di Giannantonio. (2016) Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators of Inflammation 2016, pages 1-8.
Crossref
Crossref
Yujie Liu, Dan Zhang, Yuhang Cheng & Zhili Li. (2015) Elevated serum immunoinflammation-related protein complexes are associated with psychosis. Psychiatry Research 230:1, pages 96-101.
Crossref
Crossref
Jamie Joseph, Colin Depp, Averria Sirkin Martin, Rebecca E. Daly, Danielle K. Glorioso, Barton W. Palmer & Dilip V. Jeste. (2015) Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophrenia Research 168:1-2, pages 456-460.
Crossref
Crossref
David C Henderson, Brenda Vincenzi, Nicolas V Andrea, Melissa Ulloa & Paul M Copeland. (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. The Lancet Psychiatry 2:5, pages 452-464.
Crossref
Crossref
M. Kenk, T. Selvanathan, N. Rao, I. Suridjan, P. Rusjan, G. Remington, J. H. Meyer, A. A. Wilson, S. Houle & R. Mizrahi. (2014) Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [18F]-FEPPA. Schizophrenia Bulletin 41:1, pages 85-93.
Crossref
Crossref
Katlyn Nemani, Reza Hosseini Ghomi, Beth McCormick & Xiaoduo Fan. (2015) Schizophrenia and the gut–brain axis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 56, pages 155-160.
Crossref
Crossref
Eva M. Marco, Elena Velarde, Ricardo Llorente & Giovanni Laviola. 2016. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology
155
181
.
Yuet-Keung Li, Christy Lai-Ming Hui, Edwin Ho-Ming Lee, Wing-Chung Chang, Sherry Kit-Wa Chan, Chung-Ming Leung & Eric Yu-Hai Chen. (2014) Coupling physical exercise with dietary glucose supplement for treating cognitive impairment in schizophrenia: a theoretical model and future directions. Early Intervention in Psychiatry 8:3, pages 209-220.
Crossref
Crossref
Venkataram Shivakumar, Sunil V. Kalmady, Ganesan Venkatasubramanian, Vasanthapuram Ravi & Bangalore N. Gangadhar. (2014) Do schizophrenia patients age early?. Asian Journal of Psychiatry 10, pages 3-9.
Crossref
Crossref
Hovsep Ghazaryan, Martin Petrek & Anna Boyajyan. (2014) Chronic schizophrenia is associated with over-expression of the interleukin-2 receptor gamma gene. Psychiatry Research 217:3, pages 158-162.
Crossref
Crossref
Minli Ding, Xueqin Song, Jingyuan Zhao, Jinsong Gao, Xue Li, Ge Yang, Xiujuan Wang, Amy Harrington, Xiaoduo Fan & Luxian Lv. (2014) Activation of Th17 cells in drug naïve, first episode schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 51, pages 78-82.
Crossref
Crossref
Kyoung-Sae Na, Han-Yong Jung & Yong-Ku Kim. (2014) The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, pages 277-286.
Crossref
Crossref
Xueqin Song, Xiaoduo Fan, Xue Li, Wei Zhang, Jinsong Gao, Jingping Zhao, Amy Harrington, Douglas Ziedonis & Luxian Lv. (2013) Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology 231:2, pages 319-325.
Crossref
Crossref
Annya M, Smyth, Stephen M & Lawrie. (2013) The Neuroimmunology of Schizophrenia. Clinical Psychopharmacology and Neuroscience 11:3, pages 107-117.
Crossref
Crossref
Sanil Rege & Suzanne J Hodgkinson. (2013) Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application. Australian & New Zealand Journal of Psychiatry 47:12, pages 1136-1151.
Crossref
Crossref
Xueqin Song, Xiaoduo Fan, Xinwen Song, Jianjiang Zhang, Wei Zhang, Xue Li, Jinsong Gao, Amy Harrington, Douglas Ziedonis & Luxian Lv. (2013) Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophrenia Research 150:1, pages 269-273.
Crossref
Crossref
T. White, S. Ehrlich, B.-C. Ho, D. S. Manoach, A. Caprihan, S. C. Schulz, N. C. Andreasen, R. L. Gollub, V. D. Calhoun & V. A. Magnotta. (2012) Spatial Characteristics of White Matter Abnormalities in Schizophrenia. Schizophrenia Bulletin 39:5, pages 1077-1086.
Crossref
Crossref
William R Keller, Lionel M Kum, Heidi J Wehring, Maju Mathew Koola, Robert W Buchanan & Deanna L Kelly. (2012) A review of anti-inflammatory agents for symptoms of schizophrenia. Journal of Psychopharmacology 27:4, pages 337-342.
Crossref
Crossref
Urs Meyer. (2013) Developmental neuroinflammation and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 42, pages 20-34.
Crossref
Crossref
William Parker & Jeff Ollerton. (2013) Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evolution, Medicine, and Public Health 2013:1, pages 89-103.
Crossref
Crossref
Eva M. Marco, Simone Macrì & Giovanni Laviola. 2013. Staging Neuropsychiatric Disorders. Staging Neuropsychiatric Disorders
327
348
.
Marina Díaz-Marsá, Karina S. MacDowell, Itziar Guemes, Víctor Rubio, José L. Carrasco & Juan C. Leza. (2012) Activation of the cholinergic anti-inflammatory system in peripheral blood mononuclear cells from patients with Borderline Personality Disorder. Journal of Psychiatric Research 46:12, pages 1610-1617.
Crossref
Crossref
Milica Borovcanin, Ivan Jovanovic, Gordana Radosavljevic, Slavica Djukic Dejanovic, Dragic Bankovic, Nebojsa Arsenijevic & Miodrag L. Lukic. (2012) Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. Journal of Psychiatric Research 46:11, pages 1421-1426.
Crossref
Crossref
Milawaty Nurjono, Jimmy Lee & Siow-Ann Chong. (2012) A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia. Clinical Psychopharmacology and Neuroscience 10:2, pages 61-70.
Crossref
Crossref
Lieve Desbonnet, Colm O’Tuathaigh, Gerard Clarke, Claire O’Leary, Emilie Petit, Niamh Clarke, Orna Tighe, Donna Lai, Richard Harvey, John F. Cryan, Timothy G. Dinan & John L. Waddington. (2012) Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene × environment interaction. Brain, Behavior, and Immunity 26:4, pages 660-671.
Crossref
Crossref
Y.-W. Yang & H.-C. Lin. (2012) Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study. British Journal of Dermatology 166:4, pages 899-900.
Crossref
Crossref
Nadine Correia Santos, Patrício Costa, Dina Ruano, António Macedo, Maria João Soares, José Valente, Ana Telma Pereira, Maria Helena Azevedo & Joana Almeida Palha. (2012) Revisiting Thyroid Hormones in Schizophrenia. Journal of Thyroid Research 2012, pages 1-15.
Crossref
Crossref
Eva M. Marco, Simone Macrì & Giovanni Laviola. 2012. Staging Neuropsychiatric Disorders. Staging Neuropsychiatric Disorders
275
296
.
Paula Rojas, Maria Villar, Alfonso Gonzalez, Catalina Poblete, Flora Funez, Ana Tong & Claudio Liberman. (2011) Increase in C-reactive protein and lipids in adolescents with psychiatric disease. Psychiatry Research 190:2-3, pages 372-374.
Crossref
Crossref
Urs Meyer. (2011) Anti-inflammatory signaling in schizophrenia. Brain, Behavior, and Immunity 25:8, pages 1507-1518.
Crossref
Crossref
Urs Meyer, Markus J. Schwarz & Norbert Müller. (2011) Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacology & Therapeutics 132:1, pages 96-110.
Crossref
Crossref
D. V. Jeste, O. M. Wolkowitz & B. W. Palmer. (2011) Divergent Trajectories of Physical, Cognitive, and Psychosocial Aging in Schizophrenia. Schizophrenia Bulletin 37:3, pages 451-455.
Crossref
Crossref
Eva M. Marco, Simone Macrì & Giovanni Laviola. (2010) Critical Age Windows for Neurodevelopmental Psychiatric Disorders: Evidence from Animal Models. Neurotoxicity Research 19:2, pages 286-307.
Crossref
Crossref
Monojit Debnath, Karen Doyle, Camilla Langan, Colm McDonald, Brian Leonard & Dara Cannon. (2011) Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders. Translational Neuroscience 2:2.
Crossref
Crossref
Anindya Dasgupta, Om Prakash Singh, Jayanta Kumar Rout, Tanmay Saha & Sonai Mandal. (2010) Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:7, pages 1202-1207.
Crossref
Crossref
Johannes L. Stanta, Radka Saldova, Weston B. Struwe, Jennifer C. Byrne, F. Markus Leweke, Matthius Rothermund, Hassan Rahmoune, Yishai Levin, Paul C. Guest, Sabine Bahn & Pauline M. Rudd. (2010) Identification of N-Glycosylation Changes in the CSF and Serum in Patients with Schizophrenia. Journal of Proteome Research 9:9, pages 4476-4489.
Crossref
Crossref
William W Eaton, Marianne G Pedersen, Philip R Nielsen & Preben Bo Mortensen. (2010) Autoimmune diseases, bipolar disorder, and non‐affective psychosis. Bipolar Disorders 12:6, pages 638-646.
Crossref
Crossref
Irina Bespalova, Gary Angelo, Benjamin Ritter, Enrique Rossy-Fullana, Jose Carrion-Baralt, Martina Durner & Jeremy Silverman. (2010) Mutation analysis of the C1QTNF3 gene in patients with schizophrenia. Psychiatry Research 179:2, pages 235-237.
Crossref
Crossref
Sigrun Hope, Ingrid Melle, Pål Aukrust, Nils Eiel Steen, Astrid B Birkenaes, Steinar Lorentzen, Ingrid Agartz, Thor Ueland & Ole A Andreassen. (2009) Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disorders 11:7, pages 726-734.
Crossref
Crossref
Bernhard Bogerts & Johann Steiner. (2009) Neurobiologie der Schizophrenien. Psychiatrie und Psychotherapie up2date 3:05, pages e1-e15.
Crossref
Crossref
Rodney R. Dietert & Janice M. Dietert. (2008) Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME). Toxicology 247:1, pages 61-72.
Crossref
Crossref